Feed BAX
BA

Baxter International BAX · NYSE

$22.98 -2.21% (-$0.52)

Market cap
$12.1B
Enterprise value
$19.7B
P/E
-
Forward P/E
11.5x
PEG
-
P/S
1.1x
P/FCF
17.9x
EV/EBITDA
26.2x
ROIC
-3.2%
Gross margin
30.1%
Net margin
-9.3%
Dividend yield
0.17%
Payout ratio
-
Net debt/EBITDA
10.0x
Beta
0.65
Free float
99.4%

About the company

Baxter International Inc. (BAX) is an American healthcare company specializing in the development, manufacture, and distribution of medical devices, pharmaceutical products, and biological therapies. With a broad portfolio of products focused on the care of patients with hemophilia, kidney diseases, immune disorders, and other serious health conditions, Baxter is one of the leading players in the healthcare industry. The company is known for its emphasis on innovation and quality, enabling it to provide top-notch solutions to improve the health and quality of life of patients. Baxter International also invests in research and development of new treatment methods and technologies. Baxter International Inc. (BAX) shares could be suitable for investors looking for opportunities in the healthcare sector with a focus on innovation and a broad therapeutic portfolio.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Andrew Hider

Employees

37,500

Headquarters

Deerfield

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: Repaying its net debt would take 10.0 years of operating profit.

Capital and dividends

What does the company do with the money it earns?

  • What to watch: It cut its dividend by 50% last year.

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

  • What speaks for it: The price moves less than the market (beta 0.65).

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy